West Nile virus risk assessment tool
West Nile virus (WNV) is an emerging pathogen whose ecology and epidemiology extend across multiple interfaces. As the epidemiology and transmission cycle of WNV is complex, assessing the risk of WNV being transmitted to humans is not always straightforward. Therefore, the WNV risk assessment tool has been developed to provide operational guidance in support of the risk assessment process. The tool specifically addresses two questions: definition of geographically affected areas and areas at risk of WNV transmission and the triggering of an alert for potential human WNV infection using indicators from different surveillance systems. The document is divided into three parts: key facts about WNV; description of surveillance systems used for WNV and the risk assessment tool.
Risk assessment is a continuous process and the WNV situation changes each year in Europe and will evolve further in the future. Therefore the risk assessment tool will also be regularly revised and updated in response to new evidence on the ecology of WNV in Europe as it emerges.
How are geographically affected areas and areas at risk of West Nile virus (WNV) transmission defined?
When is an alert for potential human WNV infection triggered?
The WNV risk assessment tool provides operational guidance to assist the countries in determining the risk of human transmission of WNV on their territory. Using the information gathered through the surveillance mechanisms they can ascertain the level of risk within an area. Seven possible risk levels are defined. For each risk level, the tool outlines the questions to be answered and suggests obligatory and desirable surveillance activities, as well as public health response measures. In addition, the report offers key facts about WNV and description of surveillance systems used.
The epidemiology and transmission cycle of the WNV is complex and assessing the risk of WNV being transmitted to humans is not always straightforward. Risk assessment at local, national and EU level can help the timely implementation of preparedness activities, control measures, as well as provide information to decision makers
Threat Assessment Brief: Implications of the further emergence and spread of the SARS CoV 2 B.1.1.529 variant of concern (Omicron) for the EU/EEA first update
2 Dec 2021 - The number of countries reporting SARS-CoV-2 Omicron variant of concern (VOC) cases continues to increase globally, with a total of 352 confirmed cases reported by 27 countries as of 16.00 on 1 December 2021, including 70 confirmed cases reported by 13 European Union and European Economic Area (EU/EEA) countries.
Interim public health considerations for COVID-19 vaccination of children aged 5-11 years
1 Dec 2021 - This technical report provides a set of interim public health considerations to support EU/EEA public health authorities taking decisions on the administration of COVID-19 vaccines to children aged 5 11 years.
Surveillance of COVID-19 in long-term care facilities in the EU/EEA
29 Nov 2021 - ECDC has worked with EU/EEA countries to develop a methodology for regular national reporting of existing national surveillance data on COVID-19 in LTCFs, aiming for maximum feasibility. This is to enable ECDC to communicate timely information on epidemiological trends of COVID-19 in LTCFs, in support of national and EU/EEA-level preparedness and response activities.